Unlock Growth

With the Invisalign® Flexible Payment Terms (FPT10), exclusively for OrthoFi and OrthoBanc.

Say goodbye to traditional payment hassles and hello to a more patient-friendly and profitable practice.

BOOK A CONSULTATION

 The Invisalign® Flexible Payment Terms Program (FPT10), exclusively available for OrthoFi and OrthoBanc customers, offers the opportunity to grow your practice and increase cash flow.

Instead of paying your lab fee with your current Net 30 or Net 60 terms, you pay in equal ACH payments over 10 months.

So, if your lab fee is $1,500, you would pay $150 per month starting 30 days from your Clincheck approval.

Increase Cash Flow,

Boost Conversions

& Increase Aligner Treatments

At a minimum, the average practice would experience an increased cash flow of $45,000¹.

If you lean into the benefits of the program and adopt Open Choice to let patients start treatment with lower down payment minimums, you could boost conversion, increase your aligner mix from 20% to 40%, and experience over $70,000² in higher cash inflows during the first 11 months.

That incremental growth, along with the chair time reductions that go with aligner treatment, can transform your practice.

Get More Starts

With adult aligner starts down nearly 11% in 2023³, FPT10 provides a financially sound solution to minimize the impact of adult aligner retraction

Eliminate high down payment requirements that block same-day starts and overall conversion

Enjoy higher cash inflows and reduced cash outflows for a full 11 months while you grow your revenue

See More Patients

Increase your mix of aligner cases without impacting cash flow

Since aligner treatment requires less chair time, you can maximize clinical capacity and schedule more patients per day

Navigate the staffing crisis by reducing your need for additional clinical assistants

  1. Cash inflow delta analysis with a steady 20% Invisalign®️ share and $1,500 lab fee in the FPT10 vs. net 30 terms.
  2. Revenue and net monthly cash inflows with an increase from 20% to 40% Invisalign share-of-chair based on $1,500 lab fee in the FPT10 vs. net 30 terms.
  3. Gaidge®️ US Avg a running average of all US practice data. Gaidge is a registered trademark of Gaidge, LLC.
Scroll to Top